EasyDNNNewsCalendar

Archive

EasyDNNNews

Survey: Oncologists Treat Women Over 69 With Adjuvant Radiotherapy After Lumpectomy For Early-stage Breast Cancer Despite Evidence Against Benefits.

Wednesday, October 11, 2017

Medscape (10/11, Harrison) reports a study published in the Annals Of Surgical Oncology in July found that “a large proportion of surgeons in the United States and even a good percentage of radiation oncologists still insist on treating women aged 70 years and older with adjuvant radiotherapy after they undergo lumpectomy for early-stage breast cancer,” in spite of “overwhelming evidence that adjuvant radiotherapy provides no survival benefit and very little protection against recurrence compared with no radiation.” A survey conducted in follow-up to the study revealed “that 40% of surgeons and 20% of radiation oncologists felt that omitting radiotherapy after lumpectomy was ‘unreasonable.’” In addition, “almost half of the surgeons surveyed were concerned about legal liability issues if radiotherapy were omitted and patients subsequently developed a local recurrence, as were about one quarter of radiation oncologists.” 

Patients May Be Less Likely To Choose Digital Breast Tomosynthesis Screening Mammography Because Of Potential Financial Considerations, Study Suggests.

Tuesday, October 10, 2017

HealthImaging (10/6, Thakar) reported that research suggests “patients are less likely to choose digital breast tomosynthesis screening mammography (DBTSM), despite more accurate results than traditional 2D mammography screening (2DSM), because of potential financial considerations.” The findings were published in the Journal of the American College of Radiology. 

Patients May Be Less Likely To Choose Digital Breast Tomosynthesis Screening Mammography Because Of Potential Financial Considerations, Study Suggests.

Tuesday, October 10, 2017

HealthImaging (10/6, Thakar) reported that research suggests “patients are less likely to choose digital breast tomosynthesis screening mammography (DBTSM), despite more accurate results than traditional 2D mammography screening (2DSM), because of potential financial considerations.” The findings were published in the Journal of the American College of Radiology. 

Study Seeks To Determine Whether 3-D Mammography Reduces A Woman’s Risk Of Developing Life-Threatening Breast Cancer More Than 2-D.

Friday, October 6, 2017
DOT Med News (10/5, Fischer) reports that research will seek to “determine if 3-D mammography reduces a woman’s risk of developing life-threatening breast cancer more than 2-D.” According to DOT Med News, “The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and the National Cancer Institute (NCI) have developed the Tomosynthesis Mammographic Imaging Screening Trial (TMIST) to compare the two types of digital mammography in breast cancer screenings.”

Study Seeks To Determine Whether 3-D Mammography Reduces A Woman’s Risk Of Developing Life-Threatening Breast Cancer More Than 2-D.

Friday, October 6, 2017
DOT Med News (10/5, Fischer) reports that research will seek to “determine if 3-D mammography reduces a woman’s risk of developing life-threatening breast cancer more than 2-D.” According to DOT Med News, “The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and the National Cancer Institute (NCI) have developed the Tomosynthesis Mammographic Imaging Screening Trial (TMIST) to compare the two types of digital mammography in breast cancer screenings.”
RSS
123